Profile
ALBO NVO VRTX REGN MRNA SGEN
Company Name Albireo Pharma, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $915.89M $542.69B $105.97B $105.11B $46.40B $43.15B
Employees 0.13K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Ronald H. W. Cooper Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
Trading
ALBO NVO VRTX REGN MRNA SGEN
Last Close $44.15 $127.29 $410.24 $969.97 $121.07 $228.74
High 52 $44.15 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $44.15 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High 0 % -36.21 % -8.03 % -2.35 % -12.11 % -0.07 %
Price vs. 52 Week Low 0 % 45.01 % 26.79 % 40.08 % 74.18 % 21.9 %
Total Return
ALBO NVO VRTX REGN MRNA SGEN
1 Month Return 0 % -0.13 % 1.49 % 3.36 % 15.21 % 0 %
3 Month Return 0 % 7.52 % -3.03 % 2.49 % 29.27 % 0 %
6 Month Return 0 % 25.09 % 8.83 % 17.89 % 69.71 % 7 %
9 Month Return 0 % -32.71 % 19.09 % 24.3 % 21.39 % 17.51 %
YTD Return 0 % 23.04 % 0.82 % 10.44 % 21.74 % 0 %
1 Year Return 0 % -24.43 % 19.22 % 28.96 % -8.11 % 15.39 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALBO NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -231.31 % 1.1 % 13.85 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ALBO NVO VRTX REGN MRNA SGEN
Asset Growth 5.76 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 372.11 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 388.43 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year 93.93 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -76.97 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -28.27 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -27.19 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -99.84 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 40.3 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share 86.23 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -28.27 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -6.46 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -144.34 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 21.02 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG 87.84 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -5.64 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -5.64 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -19.43 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -12.82 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -69.35 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -89.31 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 3.98 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -6.84 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2021 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ALBO NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 96.66 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -50.11 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -84.83 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -48.1 % 82.5 % 20.69 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 444.75 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 27.56 % 101.7 % 114.52 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -304.31 % 45.03 % 40.87 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -1075.16 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 12.4 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.21 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM 6.99 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 6074.7 % 248.64 % 685.54 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 13.43 % 81.71 % 42.58 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -5.6 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -5.62 11.28 14.17 36.87 -9.61 -3.73
Cash Per Share TTM 1290.82 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -265.06 % 38.24 % 38.72 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.43 % 53.85 % 92.78 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -1075.16 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -8.48 74.88 28.96 26.45 -12.64 -61.54
Price To Operating Cash Flows Ratio TTM -7.89 42.18 26.86 22.06 -16.05 -79.67
Price Cash Flow Ratio TTM -7.89 42.18 26.86 22.06 -16.05 -79.67
Income Statement (TTM)
ALBO NVO VRTX REGN MRNA SGEN
Revenue $0.04B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0.04B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 96.66% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.02B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.15B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -7.87 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ALBO NVO VRTX REGN MRNA SGEN
Long Term Debt $0.01B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.13B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.18B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.01B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.3B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ALBO NVO VRTX REGN MRNA SGEN
Net Income $-0.03B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $-0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.11B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.795
ABCL AbCellera Biologics Inc. 3.82
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.43
ABIO ARCA biopharma, Inc. 3.36
ABOS Acumen Pharmaceuticals, Inc. 3.395
ABSI Absci Corporation 4.93
ABUS Arbutus Biopharma Corporation 2.81
ABVC ABVC BioPharma, Inc. 1.11
ABVX Abivax SA American Depositary Shares 14.15
ACAD ACADIA Pharmaceuticals Inc. 17.16
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.66
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9189
ACHV Achieve Life Sciences, Inc. 4.71
ACIU AC Immune SA 2.36
ACLX Arcellx, Inc. 52.35
ACRV Acrivon Therapeutics, Inc. Common Stock 8.215
ACST Acasti Pharma Inc. 2.76
ETFs With Exposure to ALBO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.02 203.92
XBI SPDR S&P Biotech ETF 0.25 89.12
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 113.825
IWV iShares Russell 3000 ETF 0 295.86
LABU Direxion Daily S&P Biotech Bull 3X Shares 0.05 105.27
IWO iShares Russell 2000 Growth ETF 0.03 260.18
HDG ProShares Hedge Replication ETF 0 49.225
UWM ProShares Ultra Russell2000 0.01 37.915
IWC iShares Micro-Cap ETF 0.09 117.49
FHLC Fidelity MSCI Health Care Index ETF 0.01 67.03
URTY ProShares UltraPro Russell2000 0.01 44.86
BTEC Principal Healthcare Innovators ETF 0.27 36.3301
ISCB iShares Morningstar Small-Cap ETF 0.01 54.4123
ISCG iShares Morningstar Small-Cap Growth ETF 0.02 45.2312
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.02 31.9152
PSC Principal U.S. Small-Cap Multi-Factor ETF 0.04 48.3
SBIO ALPS Medical Breakthroughs ETF 0 34.35
SMLV SPDR SSGA US Small Cap Low Volatility Index ETF 0.11 110.59
SMMV iShares MSCI USA Small-Cap Min Vol Factor ETF 0.1 37.2865
VFMO Vanguard U.S. Momentum Factor ETF 0.06 148.27
VTWG Vanguard Russell 2000 Growth Index Fund 0.06 189.23
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 59.3379
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.02 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.02 16.515
AVUS Avantis U.S. Equity ETF 0 88.03
DFAU Dimensional US Core Equity Market ETF 0 36.06
DFUS Dimensional U.S. Equity ETF 0 56.35
DFAS Dimensional U.S. Small Cap ETF 0 60.8528
DFAC Dimensional U.S. Core Equity 2 ETF 0 31.4
WSML.L iShares MSCI World Small Cap UCITS ETF 0.01 7.144
QQQS Invesco NASDAQ Future Gen 200 ETF 0.9 25.62
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.01 6.642
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01 460.2
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.01 5.7215
JKK iShares Morningstar Small-Cap Growth ETF 0.03 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
Unlock